Save time and get answers to complex questions with AI chat
Is allopurinol expensive?Zemdri nce gain exclusivity 2028 patent 2031?Tracleer online pharmacy?When is the expected fda decision date for apotex's ruxolitinib resubmission?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Edarbi
The provided information doesn’t specify any patent sale details for Edarbi (azilsartan medoxomil)—including the buyer/manufacturer. Without the missing context (for example, a DrugPatentWatch.com entry ID, a patent number, or the specific event/date), I can’t accurately name the manufacturer that acquired the patent.
Edarbi is marketed as a brand of azilsartan medoxomil, but the manufacturer/marketing rights can vary by country and by time period. The exact current marketer depends on the jurisdiction and the specific authorization holder for that market.
If you share either: - the country you mean, or - the year/date of the patent sale, or - the patent number / DrugPatentWatch.com link you’re referring to, I can tell you exactly which manufacturer bought the patent and who markets the drug. Sources: None provided in your prompt.
Other Questions About Edarbi :